“Diabetes and Metabolism Disorders Medicinal Plants: A Glance at the Past and a Look to the Future 2018”: Antihyperglycemic Activity of Hamelia patens Jacq. Extracts

Table 7

Lipid profile (mg/dL) among experimental rats.

Sample	TC	Tg	LDL	HDL
HC	68.60 ± 12.93	104.80 ± 25.42	17.00 ± 4.97	35.75 ± 7.27
DC	53.00 ± 10.00	160.30 ± 71.30	12.60 ± 3.58	24.40 ± 8.73
DCV	64.50 ± 5.32	147.30 ± 73.58	12.67 ± 6.43	34.25 ± 5.06
Metformin	58.38 ± 10.70	83.29 ± 20.86	21.83 ± 4.92	32.33 ± 10.93
Acarbose	48.25 ± 7.50	47.75 ± 13.10^▪▪	22.25 ± 10.81	18.75 ± 1.5
CME 150	61.50 ± 5.80	94.75 ± 13.38	13.33 ± 1.16	36.25 ± 3.59^▲
CME 75	54.67 ± 7.37	47.67 ± 6.03^▪	32.00 ± 2.00^▪▪	13.33 ± 4.16^◊±
CME 35	44.00 ± 7.07	50.25 ± 16.76^▪	17.00 ± 4.08	20.33 ± 8.39
FME 150	77.00 ± 8.20	99.25 ± 5.85	27.67 ± 6.81^▪	41.25 ± 4.19^▪▪▲
FME 75	59.75 ± 12.42	76.50 ± 28.69	26.67 ± 3.06	23.00 ± 1.00
FME 35	60.75 ± 9.00	75.75 ± 48.42	29.67 ± 5.51^▪	22.33 ± 3.51

(TC) total cholesterol; (Tg) triglycerides; (LDL) low-density lipoproteins; (HDL) high-density lipoproteins; HC, healthy control; DC, diabetic control; DCV, diabetic control vehicle; CME 150, crude methanolic extract at a concentration of 150 mg/kg; CME 75, crude methanolic extract at a concentration of 75 mg/kg; CME 35, crude methanolic extract at a concentration of 35 mg/kg; FME 150, fractional methanolic extract at a concentration of 150 mg/kg; FME 75, fractional methanolic extract at a concentration of 75 mg/kg; FME 35, fractional methanolic extract at a concentration of 35 mg/kg. For the corresponding mean ± SD: ^▪P < 0.05 compared to the diabetic control, ^▪▪P < 0.05 compared to the diabetic control, ^±P < 0.05 compared to health control, ^▲P < 0.05 compared to acarbose, ^◊P < 0.05 compared to metformin.